Should you buy AstraZeneca (AZN)?
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
- Wide Moat Quality Franchise→Stable
- Earnings Beat Track Record→Stable
- Momentum Headwind Weakening Price Action→Stable
- +2 more pillars — see the Why tab for full reasoning
→ Full pillar scorecard with all 5 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Wide Moat Quality Franchise
Trip ifOperating margin falls below 13% for 2 consecutive quarters.
- P2Earnings Beat Track Record
Trip ifEPS surprise falls below 0% for 2 consecutive quarters.
- P3Momentum Headwind Weakening Price Action
Trip ifMomentum score rises above 4.5 and on-balance volume turns positive for 4 consecutive weeks, removing the technical headwind.
- P4Favorable Risk Reward Geometry
Trip ifPrice closes above $195.31 for 5 or more consecutive sessions, confirming the target has been reached.
- P5Institutional Accumulation Signal
Trip ifInstitutional ownership decreases by more than 3 percentage points in a single reporting period, signaling distribution rather than accumulation.
How the engine reached this verdict
TrendMatrix's engine output for AstraZeneca PLC (AZN) is HOLD_IF_HOLDING with medium conviction, score 5.6/10 at $195.15. None of the engine's positive-conviction paths (C-quality, D-momentum) cleared their gates — the F-path HOLD reflects balanced signals rather than directional conviction.
AstraZeneca PLC (AZN) sits at overall score 5.6/10 with no actively-failing gates (strongest-cleared: MOMENTUM:5.3>=4.5). HOLD flips toward BUY_WAIT when a positive-conviction path (C-quality or D-momentum) triggers; toward SELL when any of the currently-passing gates drop below threshold or three+ dimensions fall below 4 simultaneously.
The engine is not issuing fresh-money entry targets at the current verdict. The technical entry zone is around — with a technical stop near $186.27 for existing positions. Asymmetric R:R is 0.00, below the threshold (≥2.0) at which the engine would actively flag fresh capital. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).
On the bull side: Strong earnings beat streak (3/4); High-quality business; Wide economic moat. On the bear side: Analyst target reached - limited upside remaining. Active engine warnings: V8: Target reached (-0.0% upside).
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates AZN — 10-dimension breakdown →
Bull case
- ▸Strong earnings beat streak (3/4)
- ▸High-quality business
- ▸Wide economic moat
Bear case
- ▸Analyst target reached - limited upside remaining